High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma-Reference-Cited by-同舟云学术

High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma

Published:2023-04 Issue:4 Volume:5 Page:100672
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Yang Hannah,Kang Beodeul,Ha Yeonjung^ORCID,Lee Sung Hwan^ORCID,Kim Ilhwan^ORCID,Kim Hyeyeong,Lee Won Suk^ORCID,Kim Gwangil,Jung Sanghoon^ORCID,Rha Sun Young^ORCID,Gaillard Vincent E.^ORCID,Cheon Jaekyung^ORCID,Kim Chan^ORCID,Chon Hong Jae^ORCID

Funder

Ministry of Science, ICT and Future Planning

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference40 articles.

1. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma;Finn;N Engl J Med,2020

2. Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma;Cheng;J Hepatol,2022

3. Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity;Lee;Exp Mol Med,2020

4. Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma;Cheon;Liver Int,2022

5. Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy;Maesaka;Hepatol Res,2022

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosomal instability is associated with prognosis and efficacy of bevacizumab after resection of colorectal cancer liver metastasis;Annals of Medicine;2024-09-09

2. Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review);International Journal of Oncology;2024-09-05

3. Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy;Frontiers in Immunology;2024-08-30

4. Transarterial Embolization Enhances Programmed Cell Death Ligand 1 Expression and Influences CD8+T Lymphocytes Cytotoxicity in an Orthotopic Hepatocellular Carcinoma Rat Model;CardioVascular and Interventional Radiology;2024-08-05

5. Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours;Clinical and Translational Medicine;2024-08